4//SEC Filing
Daniels Mark 4
Accession 0001214659-21-003816
CIK 0001581280other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:30 PM ET
Size
8.9 KB
Accession
0001214659-21-003816
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Sale
Common Stock
2021-03-31$112.28/sh−1,167$131,031→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-31−1,167→ 36,177 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,167 underlying) - Exercise/Conversion
Common Stock
2021-03-31$26.66/sh+1,167$31,112→ 68,093 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753840
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:30 PM ET
- Size
- 8.9 KB